|
|
Post by JHam on Jul 9, 2014 19:04:47 GMT
Tengion, Inc. (Tengion) is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues. The Company focuses on creating these functional neo-organs and neo-tissues using a patient’s own cells, or autologous cells, in conjunction with its Organ Regeneration Platform. Tengion manufactures product candidates in its facilities using processes and it has implanted its neo-organs in clinical trials. The Company focuses on developing its technology to address medical needs in urologic, renal, gastrointestinal and vascular diseases.
|
|
|
|
Post by davidconrad on Jul 16, 2014 15:39:06 GMT
|
|
|
|
Post by davidconrad on Aug 14, 2014 14:25:11 GMT
|
|
|
|
Post by JHam on Dec 30, 2014 16:10:07 GMT
|
|
|
|
Post by lcd on Dec 30, 2014 16:13:28 GMT
Was just about to post the same news. I have always casually followed this company but never bought any shares. Its five year pps went from over $50 to less than one cent.
|
|
|
|
Post by HeyNow on Dec 30, 2014 16:15:22 GMT
|
|
|
|
Post by forthefuture on Dec 30, 2014 17:38:37 GMT
Just another reason for investment institutions to doubt the promise of regenerative medicine. Such a shame.
|
|
|
|
Post by selluwud on Dec 30, 2014 18:19:01 GMT
One of the better investments decisions I never made. I looked at them long and hard but decided to take a wait and see attitude which wisely was correct. Wish I had the same patience and foresight with some other investment decisions I have made.
|
|
